Stay updated on Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.
    Difference
    1%
    Check dated 2025-07-04T03:57:25.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.9%
    Check dated 2025-06-19T19:36:43.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:16:19.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    1%
    Check dated 2025-05-29T05:57:30.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T14:15:35.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version of the trial, now labeled as v2.15.0, and includes the name of the principal investigator, Scot Niglio, MD, from NYU Perlmutter Cancer Center. Additionally, the trial's focus on muscle-invasive urothelial cancer of the bladder remains, but detailed descriptions of the trial's methodology and inclusion/exclusion criteria have been removed.
    Difference
    45%
    Check dated 2025-04-16T10:25:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Gemcitabine, Radiation for Bladder Cancer Clinical Trial page.